TipRanks
Canopy Growth (DE:11L)
FRANKFURT:11L
Germany Market
11L
Canopy Growth
RESEARCH TOOLSreports

Canopy Growth (11L) Stock Forecast & Price Target

31 Followers
See the Price Targets and Ratings of:

11L Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Canopy
Growth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

11L Stock 12 Month Forecast

There Are No Analyst Ratings for DE:11L In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

11L Financial Forecast

11L Earnings Forecast

Next quarter’s earnings estimate for 11L is -€0.02 with a range of -€0.04 to -€0.01. The previous quarter’s EPS was -€0.02. 11L beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 11L has Performed in-line its overall industry.
Next quarter’s earnings estimate for 11L is -€0.02 with a range of -€0.04 to -€0.01. The previous quarter’s EPS was -€0.02. 11L beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 11L has Performed in-line its overall industry.

11L Sales Forecast

Next quarter’s sales forecast for 11L is €52.10M with a range of €50.71M to €52.87M. The previous quarter’s sales results were €51.45M. 11L beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 11L has Performed in-line its overall industry.
Next quarter’s sales forecast for 11L is €52.10M with a range of €50.71M to €52.87M. The previous quarter’s sales results were €51.45M. 11L beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 11L has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:11L
Nadine Sarwat
Bernstein
Bernstein
€1.6→€1.09
Hold
27.85%
Upside
Reiterated
06/25/26
Canopy Growth (CGC) Gets a Hold from Bernstein
Roth MKM Analyst forecast on DE:11L
Bill Kirk
Roth MKM
Roth MKM
€3.17
Buy
272.60%
Upside
Reiterated
06/20/26
Canopy Growth is still a buy, this analyst saysRoth Capital Partners analyst Bill Kirk says Canopy Growths (Canopy Growth Stock Quote, Chart, News, Analysts, Financials TSX:WEED) fourth quarter remained on a positive trajectory despite a headline miss, with international growth, Canadian adult-use share gains and MTL Cannabis contributions supporting the path toward positive Adjusted EBITDA.
Alliance Global Partners Analyst forecast on DE:11L
Aaron Grey
Alliance Global Partners
Alliance Global Partners
€1.14→€1.01
Hold
19.23%
Upside
Reiterated
06/16/26
Canopy Growth price target lowered to C$1.60 from C$1.80 at Alliance GlobalCanopy Growth price target lowered to C$1.60 from C$1.80 at Alliance Global
Canaccord Genuity Analyst forecast on DE:11L
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
€1.27
Buy
49.04%
Upside
Initiated
03/27/26
Canopy Growth initiated with a Buy at CanaccordCanopy Growth initiated with a Buy at Canaccord
ATB Cormark Capital Markets Analyst forecast on DE:11L
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
€0.89
Buy
4.33%
Upside
Upgraded
03/17/26
Analysts Offer Insights on Healthcare Companies: Canopy Growth (NASDAQ: CGC) and Doximity (NYSE: DOCS)
StoneX Analyst forecast on DE:11L
Mike Hickey
StoneX
StoneX
―
Hold
―
Upgraded
11/10/25
Canopy Growth upgraded to Hold from Sell at BenchmarkCanopy Growth upgraded to Hold from Sell at Benchmark
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:11L
Nadine Sarwat
Bernstein
Bernstein
€1.6→€1.09
Hold
27.85%
Upside
Reiterated
06/25/26
Canopy Growth (CGC) Gets a Hold from Bernstein
Roth MKM Analyst forecast on DE:11L
Bill Kirk
Roth MKM
Roth MKM
€3.17
Buy
272.60%
Upside
Reiterated
06/20/26
Canopy Growth is still a buy, this analyst saysRoth Capital Partners analyst Bill Kirk says Canopy Growths (Canopy Growth Stock Quote, Chart, News, Analysts, Financials TSX:WEED) fourth quarter remained on a positive trajectory despite a headline miss, with international growth, Canadian adult-use share gains and MTL Cannabis contributions supporting the path toward positive Adjusted EBITDA.
Alliance Global Partners Analyst forecast on DE:11L
Aaron Grey
Alliance Global Partners
Alliance Global Partners
€1.14→€1.01
Hold
19.23%
Upside
Reiterated
06/16/26
Canopy Growth price target lowered to C$1.60 from C$1.80 at Alliance GlobalCanopy Growth price target lowered to C$1.60 from C$1.80 at Alliance Global
Canaccord Genuity Analyst forecast on DE:11L
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
€1.27
Buy
49.04%
Upside
Initiated
03/27/26
Canopy Growth initiated with a Buy at CanaccordCanopy Growth initiated with a Buy at Canaccord
ATB Cormark Capital Markets Analyst forecast on DE:11L
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
€0.89
Buy
4.33%
Upside
Upgraded
03/17/26
Analysts Offer Insights on Healthcare Companies: Canopy Growth (NASDAQ: CGC) and Doximity (NYSE: DOCS)
StoneX Analyst forecast on DE:11L
Mike Hickey
StoneX
StoneX
―
Hold
―
Upgraded
11/10/25
Canopy Growth upgraded to Hold from Sell at BenchmarkCanopy Growth upgraded to Hold from Sell at Benchmark
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Canopy Growth

3 Months
Bill KirkRoth MKM
Success Rate
4/16 ratings generated profit
25%
Average Return
-15.56%
Copying Bill Kirk's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -15.56% per trade.
1 Year
Bill KirkRoth MKM
Success Rate
1/16 ratings generated profit
6%
Average Return
-53.54%
Copying Bill Kirk's trades and holding each position for 1 Year would result in 6.25% of your transactions generating a profit, with an average return of -53.54% per trade.
2 Years
Bill KirkRoth MKM
Success Rate
0/16 ratings generated profit
0%
Average Return
-70.94%
Copying Bill Kirk's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -70.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

11L Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
2
2
2
0
0
Buy
0
0
0
0
0
Hold
3
3
2
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
4
0
0
In the current month, 11L has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 11L average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

11L Stock Forecast FAQ

What is DE:11L’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:11L’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:11L, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Canopy Growth a Buy, Sell or Hold?
      Currently, no data Available
      What is Canopy Growth’s share price target?
      Currently, no data Available
      What do analysts say about Canopy Growth?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Canopy Growth?
      To buy shares of DE:11L, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.